Novel Thymoquinone Derivative TQFL28 Inhibits Triple-Negative Breast Cancer (TNBC) Invasiveness In Vitro and In Vivo

QR Code

Novel Thymoquinone Derivative TQFL28 Inhibits Triple-Negative Breast Cancer (TNBC) Invasiveness In Vitro and In Vivo

Although thymoquinone (TQ) has been reported as an anti-tumor small molecule well investigated in numerous tumors. In this study, we designed and synthesized a novel TQ derivative, TQFL28, with a molecular formula of C<sub>20</sub>H<sub>23</sub>NO<sub>2</sub>. TQF...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jiayue He, Hui Zou, Chunli Wei, Jun Du, Ting Xiao, Ting Li, Ali El-Far, Jingliang Cheng, Junjiang Fu, Xiaoyan Liu
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Series:	Current Issues in Molecular Biology
Subjects:	thymoquinone derivative TQFL28 anti-cancer invasiveness triple-negative breast cancer
Online Access:	https://www.mdpi.com/1467-3045/47/6/412
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Role of Genomics and Transcriptomics in Characterizing and Predicting Patient Response to Treatment in Triple Negative Breast Cancer (TNBC)
by: Franklin Eduardo Corea-Dilbert, et al.
Published: (2025-04-01)

Predictive Factors of Response to Neoadjuvant Chemotherapy (NACT) and Immune Checkpoint Inhibitors in Early-Stage Triple-Negative Breast Cancer Patients (TNBC)
by: Khashayar Yazdanpanah Ardakani, et al.
Published: (2025-07-01)

The effect of a drug Cisplatin and Thymoquinone material in the liver of rats after the induced of cancer in laboratary
by: Sundus W. Alabdullah, et al.
Published: (2023-02-01)

c-MYC Levels and Metabolic Parameters in Triple-Positive and Triple-Negative Breast Cancer
by: Doaa N. Abood, et al.
Published: (2025-06-01)

Characterization of Disseminated Tumor Cells (DTCs) in Patients with Triple-Negative Breast Cancer (TNBC)
by: Anne Eckardt, et al.
Published: (2025-06-01)

Thymoquinone enhances cisplatin-induced neprotoxicity in high dose
by: Ahmet Dirican, et al.
Published: (2016-01-01)

Mechanistic Evaluation of Thymoquinone Derivative-Induced Apoptosis in Human Glioblastoma Cells
by: Manmeet Kour, et al.
Published: (2025-06-01)

IQGAP1 is a Specific Target of Haldol in Triple Negative Breast Cancer
by: Mahmood Meqdad
Published: (2025-06-01)

Results of combination treatment for triple-negative breast cancer
by: M. A. Sekundova, et al.
Published: (2014-07-01)

Role of Glucocorticoid Receptor in Triple-Negative Breast Cancer
by: Raj Kumar
Published: (2025-04-01)

The Effect of Thymoquinone and Platelet-Rich Plasma on Intra-Abdominal Adhesions
by: Gökhan Karaca, et al.
Published: (2025-06-01)

Diagnostic utility of ultrasound features in identifying triple-negative breast cancer
by: Jampana Sahitya, et al.
Published: (2025-05-01)

Translational drugs targeting cancer stem cells in triple-negative breast cancer
by: Felipe P. de Oliveira, et al.
Published: (2025-09-01)

Clinical case of torpid course of metastatic triple negative breast cancer
by: E. P. Kulikov, et al.
Published: (2022-03-01)

Thymoquinone mitigates phthalate-induced reproductive toxicities in male Swiss albino mice
by: Musfika Anjir, et al.
Published: (2025-03-01)

Case Report: Palliative Care for Metastatic triple negative Breast Cancer with Cutaneous Involvement
by: Kaylee Scarnati, et al.
Published: (2025-06-01)

COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER
by: P. V. Krivorotko, et al.
Published: (2017-12-01)

Effect of thymoquinone on vitamin D metabolism in glucocorticoid-induced insulin resistance
by: Hazel Berna Göktuğ, et al.
Published: (2025-03-01)

EXPLORING THE POTENTIAL PHARMACOLOGICAL EFFECT OF THYMOQUINONE IN AMELIORATING THE ACQUISITION AND EXPRESSION OF VINCRISTINE INDUCED NEUROPATHIC PAIN IN MICE
by: Mehreen Arif, et al.
Published: (2024-03-01)

MicroRNA-based potential diagnostic, prognostic and therapeutic applications in triple-negative breast cancer
by: Qian Tang, et al.
Published: (2019-12-01)

In Silico Perspectives on Triple Negative Breast Cancer: Challenges and Progress
by: Maham Taqi, et al.
Published: (2025-06-01)

Effect of thymoquinone on NRF2 / NF-kB / MAPK pathway in methotrexate-induced rat testis injury
by: Emin Kaymak, et al.
Published: (2024-11-01)

TOMM40L promotes proliferation and migration of triple negative breast cancer cells and correlates with poor prognosis
by: ZHANG Ke, LU Jiangning, SUN Lixin, YU Long, SUN Lichao, RAN Yuliang
Published: (2025-05-01)

Omitting anthracyclines for the adjuvant treatment of patients with triple-negative breast cancer: A non-inferiority meta-analysis
by: Fabio Girardi, et al.
Published: (2025-10-01)

GGT and GSH-triggered nanoplatform for efficient gambogic acid delivery and tumor penetration in triple-negative breast cancer
by: Su Li, et al.
Published: (2025-08-01)

Chemoimmunomodulation in triple negative breast cancer: a key to maximizing anti-PD-1 chemoimmunotherapeutic efficacy
by: Mohammed O. Gbadamosi, et al.
Published: (2025-12-01)

Enhanced inhibition of triple-negative breast cancer metastases with high-dose Rujifang treatment assessed by optical flow cytometry in vivo
by: Fuli Zhang, et al.
Published: (2025-09-01)

Oral microbiome components predict response to neoadjuvant chemotherapy in triple-negative breast cancer patients
by: Xiaoyan Fu, et al.
Published: (2025-07-01)

USP44 promotes chemotherapeutic drug resistance of triple negative breast cancer through EZH2 protein stability
by: Pu Wu, et al.
Published: (2025-12-01)

EXPRESSION OF CD44 AND CD24 MARKERS IN BIOPSY SAMPLES OF TRIPLE NEGATIVE BREAST CANCER PATIENTS BEFORE TREATMENT
by: S. G. Smirnova, et al.
Published: (2020-09-01)

Pathological complete response of locally advanced triple-negative breast cancer: case report
by: V. V. Konstantinova, et al.
Published: (2024-09-01)

Citrullinated ENO1 Vaccine Enhances PD-1 Blockade in Mice Implanted with Murine Triple-Negative Breast Cancer Cells
by: Ricardo A. León-Letelier, et al.
Published: (2025-06-01)

Blood mononuclear cell molecular landscape associated with tumor progression in triple-negative breast cancer
by: M. R. Patysheva, et al.
Published: (2023-11-01)

The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative Breast Cancer: A Multicenter Cross-Sectional Study in Indonesia
by: Jeffry Beta Tenggara, et al.
Published: (2024-01-01)

The role of neoadjuvant chemotherapy of triple-negative breast cancer in St. Petersburg City Clinical Oncological Dispensary
by: A. G. Manikhas, et al.
Published: (2016-09-01)

SHCBP1 drives tumor progression in triple-negative breast cancer
by: Huiling Wang, et al.
Published: (2025-07-01)

Network‐Based Integrative Analysis to Identify Key Genes and Corresponding Reporter Biomolecules for Triple‐Negative Breast Cancer
by: Pooja Singh, et al.
Published: (2025-05-01)

Potentiating Antibody-Dependent Cellular Cytotoxicity in Triple-Negative Breast Cancer via the Humanized Anti-CD147 Antibody
by: Kanyarat Thongheang, et al.
Published: (2025-04-01)

Cytokeratin expression in breast cancer: from mechanisms, progression, diagnosis, and prognosis to therapeutic implications
by: Ensiyeh Bahadoran, et al.
Published: (2025-12-01)

Effect of body mass index on clinical and morphological characteristics of triple negative breast cancer
by: I. B. Schepotin, et al.
Published: (2014-07-01)